Letter | Published:

Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate

Abstract

Hereditary human retinal degenerative diseases usually affect the mature photoreceptor topography by reducing the number of cells through apoptosis, resulting in loss of visual function1. Only one inherited retinal disease, the enhanced S-cone syndrome (ESCS), manifests a gain in function of photoreceptors. ESCS is an autosomal recessive retinopathy in which patients have an increased sensitivity to blue light; perception of blue light is mediated by what is normally the least populous cone photoreceptor subtype, the S (short wavelength, blue) cones2,3,4,5,6,7,8. People with ESCS also suffer visual loss, with night blindness occurring from early in life, varying degrees of L (long, red)- and M (middle, green)-cone vision, and retinal degeneration. The altered ratio of S- to L/M-cone photoreceptor sensitivity in ESCS may be due to abnormal cone cell fate determination during retinal development7. In 94% of a cohort of ESCS probands we found mutations in NR2E3 (also known as PNR), which encodes a retinal nuclear receptor recently discovered to be a ligand-dependent transcription factor9. Expression of NR2E3 was limited to the outer nuclear layer of the human retina. Our results suggest that NR2E3 has a role in determining photoreceptor phenotype during human retinogenesis.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Rattner, A., Sun, H. & Nathans, J. Molecular genetics of human retinal disease. Annu. Rev. Genet. 33, 89–131 (1999).

  2. 2

    Jacobson, S.G., Marmor, M.F., Kemp, C.M. & Knighton, R.W. SWS (blue) cone hypersensitivity in a newly identified retinal degeneration. Invest. Ophthalmol. Vis. Sci. 31, 827– 838 (1990).

  3. 3

    Marmor, M.F., Jacobson, S.G., Foerster, M.H., Kellner, U. & Weleber, R.G. Diagnostic clinical findings of a new syndrome with night blindness, maculopathy, and enhanced S cone sensitivity. Am. J. Ophthalmol. 110, 124– 134 (1990).

  4. 4

    Román, A.J. & Jacobson, S.G. S cone-driven but not S cone-type electroretinograms in the enhanced S cone syndrome. Exp. Eye Res. 53, 685–690 (1991).

  5. 5

    Jacobson, S.G., Román, A.J., Román, M.I., Gass, J.D.M. & Parker, J.A. Relatively enhanced S cone function in the Goldmann-Favre Syndrome. Am. J. Ophthalmol. 111, 446–453 (1991).

  6. 6

    Kellner, U., Zrenner, E., Sadowski, B. & Foerster, M.H. Enhanced S cone sensitivity syndrome: long-term follow-up, electrophysiological and psychophysical findings. Clin. Vision Sci. 8, 425–434 (1993).

  7. 7

    Hood, D.C., Cideciyan, A.V., Roman, A.J. & Jacobson, S.G. Enhanced S cone syndrome: evidence for an abnormally large number of S cones. Vision Res. 35, 1473–1481 (1995).

  8. 8

    Greenstein, V.C. et al. The enhanced S cone syndrome: an analysis of receptoral and post-receptoral changes. Vision Res. 36, 3711–3722 (1996).

  9. 9

    Kobayashi, M. et al. Identification of a photoreceptor cell-specific nuclear receptor. Proc. Natl Acad. Sci. USA 96, 4814– 4819 (1999).

  10. 10

    Favre, M. A propos de deux cas de degenerescence hyaloideoretinienne. Ophthalmologica 135, 604–609 ( 1958).

  11. 11

    Fishman, G.A., Jampol, L.M. & Goldberg, M.F. Diagnostic features of the Favre-Goldmann syndrome. Br. J. Ophthalmol. 60, 345– 353 (1976).

  12. 12

    Fishman, G.A. & Peachey, N. Rod-cone dystrophy associated with a rod system electroretinogram obtained under photopic conditions. Ophthalmology 96, 913–918 (1989).

  13. 13

    Carmi, R., Elbedour, K., Stone, E.M. & Sheffield V.C. Phenotypic differences among patients with Bardet Biedl syndrome linked to three different loci. Am. J. Med. Genet . 59, 199–203 (1995).

  14. 14

    Willy, P.J. & Mangelsdorf, D.J. Nuclear orphan receptors: the search for novel ligands and signaling pathways. Horm. Signaling 1, 307–358 ( 1998).

  15. 15

    Blumberg, B. & Evans, R.M. Orphan nuclear receptors-new ligands and new possibilities. Genes Dev. 12, 3149 –3155 (1998).

  16. 16

    Wikler, K.C. & Rakic, P. An array of early differentiating cones precedes the emergence of the photoreceptor mosaic in the fetal monkey retina. Proc. Natl Acad. Sci. USA 91, 6534 –6538 (1994).

  17. 17

    Wikler, K.C. & Rakic, P. Development of photoreceptor mosaics in primate retina. Perspect. Dev. Neurobiol. 30, 161–175 (1996).

  18. 18

    Hendrickson, A., Bumsted, K. & Dorn, E. The development of photoreceptor-specific proteins in primate retina. 42–45 (Great Basin Visual Science Symposium, University of Utah, Salt Lake City, 1996).

  19. 19

    Szél, A., van Veen, T. & Rohlich, P. Retinal cone differentiation. Nature 370, 336 (1994).

  20. 20

    Szél, A. et al. Reversed ratio of color-specific cones in rabbit retinal cell transplants. Brain Res. Dev. Brain Res. 81, 1–9 (1994).

  21. 21

    Daniel, A., Dumstrei, K., Lengyel, J.A. & Hartenstein, V. The control of cell fate in the embryonic visual system by atonal, tailless and EGFR signaling. Development 126, 2945 –2954 (1999).

  22. 22

    Chen, F. et al. Retina-specific nuclear receptor: a potential regulator of cellular retinaldehyde-binding protein expressed in retinal pigment epithelium and Muller glial cells. Proc. Natl Acad. Sci. USA 96, 15149–15154 (1999).

  23. 23

    Adler, R. Determination of cellular types in the retina. Invest. Ophthalmol. Vis. Sci. 34, 1677–1682 (1993).

  24. 24

    Cepko, C.L. Retinal cell fate determination. Prog. Retinal Res. 12, 1–12 (1993).

  25. 25

    Bumsted, K. & Hendrickson, A. Distribution and development of short-wavelength cones differ between Macaca monkey and human fovea. J. Comp. Neurol. 403, 502– 516 (1999).

  26. 26

    Freund, C., Horsford, D.J. & McInnes, R.R. Transcription factor genes and the developing eye: a genetic perspective. Hum. Mol. Genet. 5, 1471–1488 (1996).

  27. 27

    Cepko, C.L. The roles of intrinsic and extrinsic cues and bHLH genes in the determination of retinal cell fates. Curr. Opin. Neurobiol. 9, 37–46 (1999).

  28. 28

    Jacobson, S.G. et al. Retinal degenerations with truncation mutations in the cone-rod homeobox (CRX) gene. Invest. Ophthalmol. Vis. Sci. 39, 2417–2426 (1998).

  29. 29

    Bassam, B.J., Cactano-Anolles, G. & Gresshoff, P.M. > Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal. Biochem. 196, 80– 83 (1991).

  30. 30

    Swiderski, R.E. et al. Expression pattern and in situ localization of the mouse homologue of the human MYOC (GLC1A) gene in adult brain. Brain Res. Mol. Brain. Res. 68, 64–72 ( 1999).

Download references

Acknowledgements

We thank D. Nishimura for critical suggestions; G. Hageman and the Lions Eye Bank for the kind gift of the human tissue; A. Kanis and J. Fingert for ocular tissue collection and dissection, J.J.-C. Lin and R. Reiter for use of the in situ hybridization facility; the Blodi Ocular Pathology Laboratory for tissue processing and embedding; J. Ross for technical assistance with tissue sectioning, photography and computer imaging; and E. De Castro, J. Huang, D. Marks and T. Aleman for help with all the patient-related aspects of the study. V.C.S. is an associate investigator of the Howard Hughes Medical Institute. This work was supported in part by Public Health Service research grants (EY11298, EY05627, EY10539, EY10564 and EY10900), the Foundation Fighting Blindness, the Grousbeck Family Foundation, the Carver Charitable Trusts and the Horvitz Family Foundation.

Author information

Correspondence to Val C. Sheffield.

Rights and permissions

Reprints and Permissions

About this article

Further reading

Figure 1: Phenotype of ESCS.
Figure 2: Chromatograms showing 11 of 12 mutations identified in ESCS probands.
Figure 3: Pedigrees of consanguineous kindreds with ESCS.
Figure 4: BLAST homology results depicting the protein similarity of human NR2E3 with other receptors in humans as well as other species: human NR2E3 (humNR2E3);
Figure 5: NR2E3 expression